Association of the NOD-like receptor 3 (NLRP3) gene variability with recurrent aphthous stomatitis in the Czech population

Logo poskytovatele

Varování

Publikace nespadá pod Fakultu sportovních studií, ale pod Lékařskou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

SLEZÁKOVÁ Simona BOŘILOVÁ LINHARTOVÁ Petra MASOPUSTOVÁ Lucie BÁRTOVÁ Jiřina PETANOVÁ Jitka KUKLÍNEK Pavel FASSMANN Antonín DUŠEK Ladislav IZAKOVIČOVÁ HOLLÁ Lydie

Rok publikování 2018
Druh Článek v odborném periodiku
Časopis / Zdroj Journal of Oral Pathology & Medicine
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Doi http://dx.doi.org/10.1111/jop.12694
Klíčová slova NLRP3; NOD-like receptor; polymorphism; recurrent aphthous stomatitis
Popis Background: Recurrent aphthous stomatitis (RAS) is a multifactorial disease with unclear etiopathogenesis in which disturbance of immunological processes may be involved. The aim of our study was to investigate three single nucleotide polymor- phisms (SNPs) rs3806265, rs4612666, rs10754558 in NOD-like receptor 3 (NLRP3 ), the gene encoding the component of inflammasome, in patients with RAS and healthy controls in the Czech population. Methods: A total of 207 subjects were included in this case-control study. Sixty- four patients with RAS and 143 healthy controls were genotyped by a method based on polymerase chain reaction using 5 0 nuclease TaqMan â assays. Detailed anamnestic, clinical, and laboratory data were obtained from all subjects. Results: The allele and genotype frequencies of NLRP3 polymorphisms (rs10754558 and rs3806265) between both groups were similar. However, statistically significant differences in NLRP3 rs4612666 genotypes between the patients with RAS and controls were found; carriers of the TT genotype had a higher risk of developing RAS than subjects with the CT+CC genotypes (OR = 14.69, 95%CI = 1.73-124.72, P = .004, P corr < .05). No associations between NLRP3 haplotypes and RAS were observed. Conclusions: Our study indicates that the NLRP3 rs4612666 polymorphism may be involved in the development of RAS in the Czech population.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info